Skip to content

DR. LEMMERLING M.

Active
Private limited companyfounded 2003active for 23 yearsErtbuerhoek 10, 9080 Lochristi, BelgiumKBO/BCE: BE 0480.114.861

From the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. LEMMERLING M. has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2.1m and a net result of €512,198. Equity has been growing by about 10% per year since 2019. Its solvency ranks better than 76% of 68 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 29-04-2003 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.229.044.360 9080 Lochristi, since 25-04-2003
Financial year end
31 March
Peppol
Not found in the Peppol Directory

Board and ownership

Board

Financial position

97 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2026
Gross margin
€872,110
▲ 134%
Turnover
≈ €1.7m
estimated
Profit
€512,198
▲ 185%
Equity
€2.1m
▲ 32.0%
Total assets
€2.4m
▲ 30.6%
Staff
0.8 FTE
=
Filed on 22-10-2026, 9 days before the deadlineat the National Bank
Score breakdownlowers riskLiquidity: current ratio 8.14, cash €1.4mSector: Human health activities (NACE 86)Equity €2.1m (87.9% of total assets)Size: 0.8 FTE, total assets €2.4mShow the evidence

Checked score

Score 2026
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 74% of micro companies in human health (NACE 86)
Financial strength · tick: 2025
Strong
Solvency 100=
equity 87.9% of total assets
Liquidity 99+1
short-term debt 12.1% · cash 56.4%
Profitability 95+14
return on assets 21.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025highest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €200,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.14 (7.29 in 2025), above the usual 1.5. Short-term debt is 12.1% and cash 56.4% of total assets. 12.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 88% on liquidity, 54% on profitability and 73% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 8.14, cash €1.4m
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €2.1m (87.9% of total assets)
NBB · annual accounts
lowers risk · Size: 0.8 FTE, total assets €2.4m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 22-10-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
9 days early
2025
3 days early
2024
9 days early
2023
1 day early
2022
2 days late
2021
38 days early
2020
17 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 6 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 28 October (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2026from €179,614 to €512,198 ▲ 185% View
  • Positive: 3rd largest company by total assets in Lochristi, Health and social work…in the Checked rankings No. 3 View
  • Positive: 8 profitable years in a rowprofit 2026: €512,198 8 years View
  • Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

Comparable companies

These companies have the same main activity as DR. LEMMERLING M.: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.1m and €2.9m, founded between 1998 and 2009.

CompanyTotal assetsGross margin
DR. LEMMERLING M. Lochristi€2.4m€0.9m
Dr. Philip Vanparijs Sint-Niklaas€2.1m€0.7m
MEDISCH KABINET DR QUINTENS Avelgem€2.8m€0.8m
OOGARTS N. JAENEN Maaseik€2.1m€0.9m
CABINET MEDICAL PHILIPPART & PEKUS Bastogne€2.1m€0.8m
PNEUMOCARE Gesves€2.9m€0.7m
A-RHYTHMIC Hove€2.2m€0.7m
Full comparison

Documents

Annual accounts at the NBB

All 23 annual accounts

Articles and registers

Key facts about DR. LEMMERLING M.

What is the company number of DR. LEMMERLING M.?
The company number of DR. LEMMERLING M. is 0480.114.861. The VAT number is the same number with BE in front: BE 0480.114.861.
Where is DR. LEMMERLING M. based?
The registered office is at Ertbuerhoek 10, 9080 Lochristi.Company details
What does DR. LEMMERLING M. do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. LEMMERLING M.?
The legal form of DR. LEMMERLING M. is Private limited company (BV).
When was DR. LEMMERLING M. founded?
DR. LEMMERLING M. was founded on 29-04-2003.
Is DR. LEMMERLING M. still active?
Yes, DR. LEMMERLING M. is an active enterprise in the KBO register.
How many employees does DR. LEMMERLING M. have?
DR. LEMMERLING M. had an average of 0.8 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of DR. LEMMERLING M.?
The turnover in financial year 2026 is ≈ €1.7m. This figure is estimated from the gross margin of €872,110 and 40 comparable companies (NACE 862). It probably lies between €1.1m and €2.7m.
Is DR. LEMMERLING M. profitable?
In financial year 2026, DR. LEMMERLING M. made a profit of €512,198.
Where can I find the annual accounts of DR. LEMMERLING M.?
DR. LEMMERLING M. filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
When are the next annual accounts of DR. LEMMERLING M. due?
DR. LEMMERLING M. must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.